Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
PLoS Med
    January 2018
  1. DAVIES B, Turner KME, Benfield T, Frolund M, et al
    Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort.
    PLoS Med. 2018;15:e1002483.
    >> Share

    December 2017
  2. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    >> Share

    November 2017
  3. RUDGARD WE, Evans CA, Sweeney S, Wingfield T, et al
    Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
    PLoS Med. 2017;14:e1002418.
    >> Share

  4. SHETE PB, Dowdy DW
    Measuring success: The challenge of social protection in helping eliminate tuberculosis.
    PLoS Med. 2017;14:e1002419.
    >> Share

  5. YATES TA, Tomlinson LA, Bhaskaran K, Langan S, et al
    Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort.
    PLoS Med. 2017;14:e1002457.
    >> Share

    October 2017
  6. DATTA S, Saunders MJ, Tovar MA, Evans CA, et al
    Improving tuberculosis diagnosis: Better tests or better healthcare?
    PLoS Med. 2017;14:e1002406.
    >> Share

  7. SYLVIA S, Xue H, Zhou C, Shi Y, et al
    Tuberculosis detection and the challenges of integrated care in rural China: A cross-sectional standardized patient study.
    PLoS Med. 2017;14:e1002405.
    >> Share

  8. KEITEL K, Kagoro F, Samaka J, Masimba J, et al
    A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    PLoS Med. 2017;14:e1002411.
    >> Share

  9. WHITTLES LK, White PJ, Didelot X
    Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.
    PLoS Med. 2017;14:e1002416.
    >> Share

    July 2017
  10. BRANCH-ELLIMAN W, Ripollone JE, O'Brien WJ, Itani KMF, et al
    Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
    PLoS Med. 2017;14:e1002340.
    >> Share

  11. WI T, Lahra MM, Ndowa F, Bala M, et al
    Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.
    PLoS Med. 2017;14:e1002344.
    >> Share

  12. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    >> Share

    June 2017
  13. SEALE A, Broutet N, Narasimhan M
    Assessing process, content, and politics in developing the global health sector strategy on sexually transmitted infections 2016-2021: Implementation opportunities for policymakers.
    PLoS Med. 2017;14:e1002330.
    >> Share

  14. TAYLOR MM, Korenromp E, Wi T
    Pathways and progress to enhanced global sexually transmitted infection surveillance.
    PLoS Med. 2017;14:e1002328.
    >> Share

    February 2017
  15. COX H, Dickson-Hall L, Ndjeka N, Van't Hoog A, et al
    Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002238.
    >> Share

    January 2017
  16. KENDALL EA, Shrestha S, Cohen T, Nuermberger E, et al
    Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
    PLoS Med. 2017;14:e1002202.
    >> Share

  17. NIKOLAY B, Salje H, Sturm-Ramirez K, Azziz-Baumgartner E, et al
    Evaluating Hospital-Based Surveillance for Outbreak Detection in Bangladesh: Analysis of Healthcare Utilization Data.
    PLoS Med. 2017;14:e1002218.
    >> Share

    October 2016
  18. CASALI N, Broda A, Harris SR, Parkhill J, et al
    Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study.
    PLoS Med. 2016;13:e1002137.
    >> Share

  19. KUNKEL A, Cobelens FG, Cohen T
    Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
    PLoS Med. 2016;13:e1002142.
    >> Share

  20. SUBBARAMAN R, Nathavitharana RR, Satyanarayana S, Pai M, et al
    The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.
    PLoS Med. 2016;13:e1002149.
    >> Share

  21. HOUBEN RM, Dodd PJ
    The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    PLoS Med. 2016;13:e1002152.
    >> Share

    September 2016
  22. HORTON KC, MacPherson P, Houben RM, White RG, et al
    Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    PLoS Med. 2016;13:e1002119.
    >> Share

    August 2016
  23. SEUNG KJ, Franke M, Linton SW
    Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
    PLoS Med. 2016;13:e1002062.
    >> Share

  24. LEE PH, Fu H, Lai TC, Chiang CY, et al
    Glycemic Control and the Risk of Tuberculosis: A Cohort Study.
    PLoS Med. 2016;13:e1002072.
    >> Share

    January 2016
  25. LEWNARD JA, Antillon M, Gonsalves G, Miller AM, et al
    Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak.
    PLoS Med. 2016;13:e1001947.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016